Add DVAX to watchlist(s)

You Should Create a Watchlist In The First Place.

Profile

Company Name

Dynavax Technologies Corporation

Symbol

DVAX

Currency

USD

Exchange

Nasdaq

Head Quarter

United States, EmeryVille

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Website

https://www.dynavax.com

ISIN

US2681582019

CIK

1029142

CUSIP

268158201

UEI

LEI

Business Description

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited;